Good. Now I have a complete picture of every line. Here's the fully comprehensive breakdown with everything included:
๐ฉธ Hematology PrepLadder RR XI - COMPLETE Breakdown (No Skips)
SECTION 1: Beta-Thalassemia Major
What is it (simple)?
A genetic disorder where both copies of the beta-globin gene are defective, so the body cannot make normal adult hemoglobin (HbA). The bone marrow compensates by over-expanding - which causes bone deformities. The patient needs blood transfusions to survive.
The 3 Clinical Images Explained
Image 1 - Chipmunk Facies:
The marrow inside facial bones expands trying to make more RBCs. This pushes the cheekbones and jaw outward, making the face look like a chipmunk's puffy cheeks. You see this in thalassemia and sickle cell disease.
Image 2 - Widening of Diploic Spaces / Hair-on-End Appearance:
The diploic space is the spongy layer of bone in the skull. When marrow expands here, the outer skull table gets pushed outward, creating vertical striations on X-ray that look like hair standing on end. Classic skull X-ray finding.
Image 3 - Transfusion Bag:
These patients are "transfusion-dependent" - they need packed RBC (PRBC) transfusions every 2-4 weeks to maintain a safe hemoglobin level and suppress the overactive but ineffective marrow.
MCQ: Prenatal Diagnosis
- Answer: Gene sequencing (beta-globin gene sequencing)
- Why not HPLC? HPLC is the best test for diagnosing thalassemia in a born child - it separates different hemoglobin fractions. But a fetus doesn't have enough blood or mature hemoglobin to test. You go straight to the gene.
- Why not Hb electrophoresis? Same reason - protein-level test, not useful prenatally.
- NESTROFT = Naked Eye Single Tube Red Cell Osmotic Fragility Test. Used for mass screening of thalassemia trait in communities - a very basic cheap test.
SECTION 2: Blood Transfusion Complications
Most Important Reactions (FMGE Favorite)
| Reaction | Most Common? | Details |
|---|
| FNHTR | โ
Most common OVERALL | Fever + chills during transfusion. Cytokines in stored blood attack white cell antigens |
| TACO | โ
Most common cause of DEATH (> TRALI) | Volume overload โ high BP, distended neck veins, raised BNP/pro-NT-BNP |
| TRALI | 2nd most fatal | Donor antibodies (from multiparous women) attack recipient lung endothelium โ bilateral infiltrates, low BP, normal BNP |
| Acute Hemolytic Reaction | - | ABO mismatch โ flank pain + hemoglobinuria (cola-coloured urine) |
| Anaphylactic Reaction | - | Rhonchi, cyanosis, BP drop - occurs within minutes |
TACO vs TRALI Comparison Table (from the notes - very important)
| Feature | TACO | TRALI |
|---|
| Pulse Rate | โ | โ |
| Blood Pressure | โ (HIGH) | Normal |
| JVP / Neck Veins | โ (Distended) | Normal |
| CXR: CT Ratio (heart size) | โ (enlarged heart) | Normal |
| Pro-NT-BNP | โ (> 1000 pg/mL) | Normal |
Clinical tip:
- TACO = Heart can't handle volume โ it stretches โ releases pro-NT-BNP as a distress signal
- TRALI = Antibodies from donor blood (especially from women who have had multiple pregnancies - grand multiparas) attack the recipient's lung lining
Classic TRALI Case from the notes:
22-year-old woman, 1 hour after 1 unit pRBC โ breathlessness, SpO2 82%, BP 80/50 mmHg (LOW), bilateral crepitations, no raised JVP, CXR bilateral diffuse infiltrates, BNP normal โ This is TRALI (not TACO, because BP is low and BNP is normal)
SECTION 3: Massive Blood Transfusion - Metabolic Effects
Why Metabolic Alkalosis?
Blood is stored in CPDA (Citrate-Phosphate-Dextrose-Adenine) solution.
- In the liver: Citrate โ Bicarbonate (HCOโโป) = alkaline substance โ Metabolic alkalosis
Example: Imagine citrate as lemon juice. Once the liver processes it, it turns into "baking soda" (bicarbonate). Too much baking soda in the blood = alkalosis.
Why Hypocalcemia?
- Citrate chelates (grabs onto) ionized calcium โ calcium becomes unavailable โ Hypocalcemia โ Tetany (muscle spasms, carpopedal spasm)
CPDA Breakdown (each component has a job)
| Component | Job |
|---|
| Citrate | Prevents clotting (anticoagulant) - but also chelates calcium |
| Phosphate | โ 2,3-BPG โ Right shift of ODC (hemoglobin releases oxygen more easily to tissues) |
| Dextrose | Sugar = nutrition for stored RBCs |
| Adenine | RBCs make ATP (energy molecule) โ cells survive longer |
- CPDA shelf life = 35 days
- SAGM (Saline-Adenine-Glucose-Mannitol) = 42 days
Immediately after transfusion: Hyperkalemia + Hypocalcemia
When RBC bags sit for a while, the RBCs slowly leak potassium into the fluid above them (supernatant). When you transfuse this, the recipient suddenly gets a potassium load โ Hyperkalemia. Combined with citrate chelating calcium โ Hypocalcemia. Answer = 1 and 3.
Infection Risks - "Extra Mile" (HIGH YIELD)
| Condition | Organism | Memory hook |
|---|
| Hyposplenism / Splenectomy | Encapsulated organisms (H. influenzae, Meningococcus, Pneumococcus) | Spleen is the "filter" for capsule-coated bacteria. No spleen = no filter |
| Iron Overload (Hemosiderosis) | Listeria and Yersinia | Both are siderophilic - they love iron. More iron = feast for them |
| Neutropenia | Pseudomonas and Candida | Neutrophils are the frontline against these. No neutrophils = open season |
SECTION 4: Multiple Myeloma (Plasmacytoma)
What is it?
Cancer of plasma cells in the bone marrow. Plasma cells are mature B-lymphocytes whose job is to produce antibodies. In myeloma, a single plasma cell clone goes rogue and produces massive amounts of one abnormal antibody called M-protein (paraprotein) - and the monoclonal light chains spill into urine as Bence-Jones proteins.
Prognosis
- Primarily based on serum ฮฒ2-microglobulin and serum albumin levels
- High ฮฒ2-microglobulin + low albumin = bad prognosis
Leading Cause of Death = Infection
(The abnormal plasma cells crowd out normal immunoglobulin production โ patient is immunocompromised)
Leading Cause of Renal Failure = Two mechanisms:
- Hypercalcemia (calcium nephropathy)
- Bence-Jones proteins / Light chain cast nephropathy (light chain fragments clog the kidney tubules like a drain blockage)
Most Common Site of Bony Lytic Lesions:
Spine > Pelvis > Ribs > Skull
CRAB Features
| Letter | Feature | Mechanism |
|---|
| C | Hypercalcemia | Tumor osteoclasts destroy bone โ calcium released into blood |
| R | Renal failure | Light chains + hypercalcemia damage kidneys |
| A | Anemia | Plasma cells invade and replace normal marrow |
| B | Bony lytic lesions | Osteoclast activation destroys bone (lytic = no new bone formed, unlike metastases which can be sclerotic) |
Diagnostic Criteria
- Bone marrow biopsy โ plasma cells >10% = Multiple Myeloma
- No CRAB features โ >60% plasma cells needed (smoldering myeloma threshold)
Plasma Cell Microscopy Features
| Feature | What it looks like | Simple explanation |
|---|
| Clock-face chromatin | Dark chromatin clumped at the edges of the nucleus, like numbers on a clock | Classic plasma cell nucleus pattern |
| Russell bodies | Round pink blobs inside the cytoplasm | Accumulated excess immunoglobulin inside the cell |
| Dutcher bodies | Same blobs but inside the nucleus | Intranuclear immunoglobulin deposits |
| Mott cells | Plasma cell stuffed full of Russell bodies | Overloaded plasma cell |
| Flame cells | Plasma cell with red-staining edges | Seen in IgA myeloma especially |
Diagnosis
- Screening test: SPEP/UPEP โ M-spike (church spire appearance) on electrophoresis graph
- IOC: Bone Marrow Biopsy
- X-ray skull: Punched-out lytic lesions (discrete holes like a hole-punch)
- Urine dipstick is NEGATIVE for Bence-Jones proteins - dipstick only detects albumin, not immunoglobulin light chains. Need UPEP (urine protein electrophoresis).
Treatment
- Daratumumab + Lenalidomide + Dexamethasone + Bortezomib
- Bortezomib = Proteasome inhibitor. Proteasomes are the cell's garbage disposal system that breaks down misfolded proteins. Blocking them causes protein buildup โ toxic to cancer cells.
- Autologous stem cell transplant = patient's own stem cells collected โ high-dose chemo โ re-infuse own cells. Done in NHL, HL, and MM.
SECTION 5: Acute Myeloid Leukemia (AML)
What is it?
Cancer of immature myeloid precursor cells (blasts) that crowd the bone marrow and spill into blood. "Acute" means it progresses rapidly without treatment.
Hallmarks
- Auer rods = pink/red rod-shaped structures inside blast cells on peripheral smear. These are fused granules. Pathognomonic (defining feature) of AML.
- MPO (Myeloperoxidase) positivity = special stain. Confirms myeloid lineage. Distinguishes AML from ALL.
- Markers: CD13, CD14, CD33, CD61
- CD61 = megakaryocyte marker โ AML-M7 (Acute Megakaryocytic Leukemia)
- M7 is associated with Down Syndrome
AML Subtypes Key Points
| Subtype | Special Feature |
|---|
| M3 (APML) | t(15;17) + DIC. Treated with ATRA (NOT standard chemo) |
| M4 + M5 | Gum hyperplasia (monocytic infiltration of gums) |
| M7 | Down syndrome, CD61+ |
Chloroma (Granulocytic Sarcoma)
- AML blasts deposit outside the bone marrow, forming a solid tumour in soft tissues (e.g., the orbit of the eye โ "proptosis" in a leukemia child)
- Appears greenish due to MPO enzyme content
- Image in notes: Blood cancer cells multiply aggressively and deposit in the skin of the orbit
M3 / APML - The Most Important AML Subtype
Pathophysiology:
- t(15;17) โ fuses PML gene with RARA (Retinoic Acid Receptor Alpha) โ fusion protein blocks promyelocyte differentiation โ promyelocytes accumulate โ their granules trigger DIC
- DIC Lab: โBT, โPT, โaPTT (all clotting tests prolonged because clotting factors are consumed)
Treatment = ATRA (All-Trans-Retinoic Acid) or Arsenic Trioxide
- ATRA forces those stuck promyelocytes to finally mature and differentiate
- Standard chemotherapy (7+3) is NOT given in M3
Differentiation Syndrome:
- Blasts rapidly differentiate โ cytokine storm โ pulmonary endothelial leak โ pulmonary edema
- Patient on ATRA, around day 5 develops: fever, breathlessness, bilateral lung infiltrates
- Treatment: Start dexamethasone. CONTINUE ATRA (do not stop it)
AML Standard Chemotherapy: 7+3 Regimen
- 7 days Cytarabine + 3 days Daunorubicin
- IOC = Flow cytometry on BMA specimen
Key Leukemia Statistics
- Most common blood cancer in children = ALL
- Most common blood cancer in adults = CLL
- Radiation is NOT a risk factor for CLL (but it is for AML, ALL, CML)
EXTRA MILE: All 4 Leukemias Compared
| Condition | Clinical Features | IOC |
|---|
| ALL | Child; CNS leukemia, testis lump; anemia, bleeding, sternal tenderness, bone pain, HSM | BMA |
| AML | Adult / Child with Down syndrome; Chloroma, gingival hyperplasia; anemia, bleeding, sternal tenderness, bone pain | BMA |
| CML | Anemia + massive splenomegaly | FISH โ PCR |
| CLL | Anemia + cervical lymphadenopathy | Flow cytometry on peripheral blood |
SECTION 6: Chronic Lymphocytic Leukemia (CLL)
What is it?
Cancer of mature but dysfunctional B-lymphocytes. The cells look mature under the microscope but cannot do their job (make antibodies). They accumulate in blood, marrow, and lymph nodes.
Key Features
Smudge cells: CLL B-cells are extremely fragile. When the lab technician smears blood on a slide, these cells get crushed and form "smudge" or "smear" artifacts. This is the classic peripheral smear finding.
AIHA (Autoimmune Hemolytic Anemia):
- CLL B-cells are immunoincompetent - they can't distinguish self from non-self
- They produce antibodies against the patient's own RBCs โ hemolysis
- Peripheral smear shows spherocytes (round RBCs that lost their normal biconcave shape)
- Coombs test positive (detects antibodies on RBC surface)
CLL Clinical Presentation
- Geriatric patient (>60 years) with anemia and discrete, rubbery cervical lymphadenopathy
- If there is a disproportionate increasing trend in ALC (Absolute Lymphocyte Count) for 3 continuous months โ workup for CLL
- Workup findings: Autoimmune hemolytic anemia, thrombocytopenia, โTLC, โALC
IOC: Flow Cytometry on Peripheral Blood
- Markers: CD19, CD20, CD23 + CD5
- CD5 is normally a T-cell marker, but CLL B-cells aberrantly express it - a classic immunophenotypic quirk
Treatment by Patient Category
| Patient | Treatment |
|---|
| Asymptomatic elderly | Observation (watch and wait - disease can be very indolent) |
| Symptomatic elderly | Ibrutinib (DOC) = BTK inhibitor. BTK = Bruton's Tyrosine Kinase, needed for B-cell survival signaling. Block it = B-cells die. |
| High tumor burden | Venetoclax + Obinutuzumab |
| Young, fit patient | FCR = Fludarabine + Cyclophosphamide + Rituximab |
EXTRA MILE: CLL vs Mantle Cell Lymphoma (common confusion)
| Feature | CLL | Mantle Cell Lymphoma |
|---|
| CD5 | โ
Positive | โ
Positive |
| CD23 | โ
Positive | โ Negative |
| Cyclin D1 | Negative | โ
Positive |
| Translocation | None | t(11;14) |
SECTION 7: Chronic Myeloid Leukemia (CML)
What is it?
A myeloproliferative disorder - uncontrolled proliferation of myeloid cells (granulocytes mainly). Caused by the Philadelphia chromosome.
The Philadelphia Chromosome
- t(9;22) = chromosomes 9 and 22 swap segments
- This creates the BCR-ABL1 fusion gene on the shortened chromosome 22
- BCR-ABL1 = constitutively active (always ON) tyrosine kinase โ non-stop cell division
- Result: Massive white cell count โ blood becomes sludgy โ Leucostasis
Leucostasis Features (sluggish blood flow)
- Lungs: Low SpOโ (hypoxia)
- Brain: Drowsiness, confusion
- Priapism: Painful sustained penile erection (blood sludges in penile vessels)
- Blindness: Retinal vessel sludging
Key Keywords in CML
Massive Splenomegaly (differential):
- Child with neurodegenerative features โ Gaucher's disease
- Child from Bihar/West Bengal โ Kala-azar (Visceral Leishmaniasis)
- Adult โ CLL (most common cause of massive splenomegaly in adults)
Shift to the Left:
- Immature myeloid cells (metamyelocytes, myelocytes, promyelocytes) pour into the blood
- Normally only mature neutrophils are in blood - seeing these precursors = left shift
- Multiple classes (different levels of immaturity) show uncontrolled reproduction
Low NAP Score:
- NAP = Neutrophil Alkaline Phosphatase. Normally active in healthy neutrophils.
- In CML, the neutrophils are malignant and functionally dead โ NAP is low
- Normal/high NAP = reactive leukocytosis (infection/stress). Low NAP = CML.
- High serum B12 = released from the large mass of dying/turning-over white cells
Basophilia: High basophil count is a hallmark of CML - helps differentiate from other causes of high WBC
IOC = FISH on BMA or PCR for BCR-ABL1
Treatment
- Imatinib mesylate (Gleevec) = 1st generation TKI (Tyrosine Kinase Inhibitor). Fits into the BCR-ABL1 kinase pocket and blocks it.
- T315I mutation = the "gatekeeper" resistance mutation
- Threonine at position 315 โ changed to Isoleucine in the BCR-ABL kinase domain
- This change closes off the binding pocket โ imatinib and 2nd-gen TKIs (dasatinib, nilotinib) cannot bind
- Only Ponatinib (3rd-gen TKI) works against T315I
SECTION 8: Hodgkin Lymphoma (HL)
What is it?
A lymph node cancer characterized by Reed-Sternberg (RS) cells - large abnormal B-cells with distinctive "owl eye" nucleoli.
RS Cell
- Owl-eye appearance = two large prominent eosinophilic (pink) nucleoli that look like owl eyes
- CD15+ and CD30+ (classic RS cell markers)
- 9p24 amplification โ PD-L1 overexpression = RS cells express PD-L1, which helps them hide from the immune system
Why Good Prognosis?
- Contiguous spread = HL spreads to adjacent lymph node groups in order (neck โ chest โ abdomen), NOT random jumping. So you can predict where it is and treat it with targeted radiation.
- Lymphatic spread = stays in lymphatic system longer before blood spread
Clinical Presentation
- Young adult/child with low-grade fever, weight loss, night sweats (B symptoms)
- Rubbery, non-tender cervical lymphadenopathy
- IOC = Excision lymph node biopsy
HL Subtypes (HIGH YIELD TABLE)
| Subtype | Key Features |
|---|
| Nodular Sclerosis | Most common OVERALL; CD15/30+; fibrous bands on biopsy; young women |
| Mixed Cellularity | Most common in India; shows classical RS cells; associated with EBV and HIV |
| Lymphocyte Rich | Good prognosis |
| Lymphocyte Depleted | Worst prognosis |
| Nodular Lymphocyte Predominant (NLPHL) | Best prognosis; slow growing; atypical; Popcorn cells (L&H cells); CD20+, CD15/30 NEGATIVE |
Treatment
| Drug | Side Effect |
|---|
| Adriamycin / Doxorubicin | Cardiotoxicity |
| Bleomycin | Pulmonary fibrosis |
| Vinblastine | Peripheral neuropathy |
| Dacarbazine | Nausea/vomiting |
- Early-stage HL = Radiation therapy
SECTION 9: Burkitt Lymphoma
What is it?
Extremely aggressive B-cell lymphoma. Classic presentation = African child with jaw swelling (endemic type associated with EBV).
EBV-Induced Translocations
All involve chromosome 8 carrying c-MYC:
- t(8;14) = c-MYC fused with Immunoglobulin Heavy Chain (IgH) promoter on chr 14 โ most common (~80%)
- t(8;22) = c-MYC fused with Ig lambda light chain
- t(2;8) = c-MYC fused with Ig kappa light chain
c-MYC is an oncogene - a master regulator of cell growth and proliferation. When fused with a constantly active immunoglobulin promoter, c-MYC is permanently switched ON โ uncontrolled, explosive proliferation.
Histology
- IOC: Excision lymph node biopsy โ Starry sky appearance
- Scattered pale macrophages (stars) against a dense background of dark lymphoma cells (night sky). The macrophages are eating the dead cancer cells - so many cells are dying and being cleaned up, it looks like stars.
Tumor Lysis Syndrome (TLS)
Burkitt has the highest risk of TLS because the tumor doubling time = 48 hours (among the fastest of any cancer).
When you kill these cells with chemotherapy, they all rupture at once and release their contents:
| Released substance | Effect |
|---|
| โ Phosphate (POโ) | From cell membranes |
| โ Calcium | Phosphate binds calcium โ hypocalcemia |
| โ Potassium (K+) | From inside ruptured cells |
| โ Uric acid | From broken-down DNA (purines โ xanthine โ uric acid) |
| โ Acute Tubular Necrosis | Urate crystals and calcium phosphate precipitate in kidney tubules โ renal AKI |
Treatment
CODOX-M + Rituximab:
- Cyclophosphamide
- Oncovin (Vincristine)
- Doxorubicin
- OX-M component: Ifosfamide, Etoposide, Cytarabine (Ara-C)
SECTION 10: Non-Hodgkin Lymphoma (NHL)
Key Associations (FMGE Staple)
| Association | Lymphoma Type |
|---|
| Most common subtype | DLBCL (Diffuse Large B-Cell Lymphoma) |
| Most common in HIV patients | DLBCL - immunoblastic subtype |
| H. pylori | MALToma (MALT = Mucosa-Associated Lymphoid Tissue). B-cell NHL. Can REGRESS after H. pylori eradication with antibiotics alone |
| HHV-8 | Primary Effusion Lymphoma (rare, occurs in body cavities - pleura, pericardium) |
| HCV | Marginal Zone Lymphoma |
| U-shaped nucleus + t(2;5) | Anaplastic Large Cell Lymphoma (ALCL) |
Cutaneous T-Cell Lymphoma
Progression:
- Early / Localized = Mycosis Fungoides (CTCL)
- Starts as itchy skin plaques/patches
- Histology: Pautrier microabscesses = T-cells clustering in the epidermis
- Late / Disseminated = Sรฉzary Syndrome
- Leukemic phase - malignant T-cells circulate in blood
- Sรฉzary cells = T-cells with cerebriform (brain-like wrinkled) nuclei in blood smear
Flower cells:
- Seen in Adult T-Cell Leukemia / Lymphoma (ATLL)
- Associated with HTLV-1 (Human T-cell Lymphotropic Virus type 1)
- Nuclei of malignant T-cells have petal-like indentations, resembling a flower
Spread Pattern
- Hematogenous spread โ multiple groups of LN involved โ Bad prognosis
- (Unlike HL which spreads in orderly contiguous fashion - NHL jumps around)
IOC = Excision lymph node biopsy + Flow cytometry
Treatment = R-CHOP
| Drug | Full Name |
|---|
| R | Rituximab (anti-CD20 monoclonal antibody) |
| C | Cyclophosphamide |
| H | Hydroxy-Daunomycin (Doxorubicin) |
| O | Oncovin (Vincristine) |
| P | Prednisone (steroid) |
SECTION 11: Beta-Thalassemia (Full Recap Section)
Full Clinical Picture
- Chipmunk facies (bone marrow expansion in facial bones)
- Anemia with splenomegaly - the spleen enlarges due to extramedullary hematopoiesis (the spleen tries to make blood cells outside the marrow because the marrow fails)
- Target cells on peripheral smear + increased reticulocyte count
- Target cells = RBCs with a bullseye pattern. Formed because of excess membrane relative to hemoglobin. In thalassemia, alpha-4 tetramers form (HbH) because there's no beta chain to pair with.
Investigations in Order
- Beta-globin gene sequencing = Best for prenatal testing (before birth)
- HPLC + Hb electrophoresis = Best for diagnosis (after birth)
Treatment
- Definitive cure = Allogenic stem cell transplantation (donor stem cells replace the patient's defective marrow)
- Supportive (survival) = Recurrent PRBC transfusion + Iron chelator (Deferoxamine/Deferasirox)
Iron Overload Complications (from repeated transfusions = Hemosiderosis / Bronze Diabetes)
| Organ | Effect |
|---|
| Skin | Brown discolouration |
| Pancreas | Iron deposits โ pancreatic damage โ Diabetes (hence "Bronze Diabetes") |
| Liver | Iron deposits โ Liver cirrhosis |
| Heart | Cardiomyopathy |
SECTION 12: Lab Findings in Anemias (Complete Table)
| Test | Iron Deficiency Anemia | Sideroblastic Anemia | Anemia of Chronic Disease |
|---|
| Serum Iron | โ Low | โ High | โ Low |
| Serum Ferritin | โ Low | โ High | โ High |
| TIBC | โ High | โ Low | โ Low |
Key rule: Serum ferritin is inversely proportional to TIBC
Anemia of Chronic Disease - Mechanism
- Hepcidin (made by the liver) is elevated in inflammation
- Hepcidin inhibits the utilization of iron from ferritin โ iron stays locked up in stores
- Seen in: SLE, RA, UC, Crohn's
- Starts as normocytic normochromic โ can become microcytic hypochromic over time
Cell Inclusions - Stain Table (HIGH YIELD)
| Inclusion | Stain Used | Disease |
|---|
| Heinz bodies | Supravital stain | G6PD deficiency (X-linked recessive) - denatured hemoglobin after oxidative stress |
| Howell-Jolly bodies | Wright-Giemsa stain | Hyposplenism / Hereditary Spherocytosis (HS: Autosomal Dominant) - nuclear remnants in RBCs |
| Pappenheimer bodies | Wright-Giemsa stain | Sideroblastic anemia (e.g., lead poisoning) - iron deposits in mitochondria |
RBC Shape Abnormalities
| Shape | Disease | Appearance |
|---|
| Golf ball inclusions | HbH disease - Alpha thalassemia | Precipitation of HbH (beta-4 tetramers) that form when all alpha chains are absent |
| Acanthocytes | Abetalipoproteinemia, liver disease | Asymmetrical irregular spikes |
| Echinocytes (burr cells) | Vitamin E deficiency, uremia | Equidistant, regular spikes (like a sea urchin or cactus) |
๐ฏ FMGE Insights - Complete High-Yield Hits
Translocations Master Table (Memorize This)
| Translocation | Gene | Disease |
|---|
| t(9;22) | BCR-ABL1 | CML (Philadelphia chromosome) |
| t(15;17) | PML-RARA | AML-M3 (APML) |
| t(8;14) | c-MYC + IgH | Burkitt Lymphoma |
| t(14;18) | BCL-2 | Follicular Lymphoma |
| t(11;14) | Cyclin D1 | Mantle Cell Lymphoma |
| t(2;5) | ALK | ALCL |
Treatment Drug-Mechanism Pairs
| Drug | Mechanism | Used in |
|---|
| Imatinib | TKI (BCR-ABL inhibitor) | CML |
| Ibrutinib | BTK inhibitor | CLL |
| Bortezomib | Proteasome inhibitor | Multiple Myeloma |
| ATRA | Differentiation agent | AML-M3 |
| Rituximab | Anti-CD20 monoclonal Ab | CLL, NHL, Burkitt |
| Venetoclax | BCL-2 inhibitor | CLL (high burden) |
| Ponatinib | 3rd-gen TKI | CML with T315I mutation |
Do-Not-Mix-Up Points
- TACO = HIGH BP + HIGH BNP. TRALI = NORMAL BP + NORMAL BNP
- FNHTR = most common transfusion reaction. TACO = most common cause of death.
- Urine dipstick NEGATIVE for Bence-Jones proteins (only detects albumin)
- NAP score LOW in CML (reactive leukocytosis has HIGH NAP)
- M3-APML: Give ATRA, NOT standard 7+3 chemo. If differentiation syndrome โ dexamethasone + CONTINUE ATRA
- CLL: CD5 positive B-cells (normally CD5 is a T-cell marker)
- Mantle Cell: CD5+, CD23-, Cyclin D1+ (vs CLL: CD5+, CD23+)
- NLPHL (Nodular Lymphocyte Predominant HL) = best prognosis, popcorn cells, CD20+, CD15/30 NEGATIVE - this is the atypical HL
- Mixed Cellularity HL = most common in India (not Nodular Sclerosis which is most common overall)
- Most common blood cancer in children = ALL; in adults = CLL
- Radiation is NOT a risk factor for CLL (unique among leukemias)
- MALToma can regress with H. pylori eradication alone
- Burkitt = highest TLS risk. Tumor doubling time = 48 hours.
- Iron overload โ Bronze Diabetes (skin + pancreas + liver)
- Deferoxamine / Deferasirox = iron chelators used in thalassemia iron overload
- HPLC = best diagnostic test for thalassemia in a born child; gene sequencing = best for prenatal
- Anemia of chronic disease โ high hepcidin โ iron trapped in stores โ ferritin high, TIBC low
- Howell-Jolly bodies = hyposplenism (Wright-Giemsa stain). Heinz bodies = G6PD (supravital stain).
- ABVD side effects: Adriamycin = cardiotoxic; Bleomycin = pulmonary fibrosis; Vinblastine = peripheral neuropathy
- T315I mutation in CML = resistant to all TKIs except Ponatinib